Apixaban not superior to standard care after TAVR
The blood thinner apixaban was not superior to standard of care following transcatheter aortic valve replacement (TAVR), according to findings […]
(HealthDay)—For moderate-to-severe plaque psoriasis, bimekizumab is more efficacious than ustekinumab and placebo, according to a study published in the Feb. […]superior
Bimekizumab superior to ustekinumab for plaque psoriasis